FibroBiologics, Inc.

FBLG · Nasdaq · SIC 2834: Pharmaceutical Preparations
71
SEC Filings

Business Summary

1 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 91 Item 1C. Cybersecurity 91 Item 2. Properties 92 Item 3. Legal Proceedings 92 Item 4. Mine Safety Disclosures 92 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 92 Item 6. Reserved 93 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 93 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 104 Item 8. ...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionFBLGdiscussed_in_filing Cybersecurity
topic_mentionFBLGdiscussed_in_filing Cybersecurity
topic_mentionFBLGdiscussed_in_filing Cybersecurity
topic_mentionFBLGdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001193125-26-066965EDGAR100K words
2025-03-312024-12-310001641172-25-001691EDGAR—
2024-02-292023-12-310001493152-24-008361EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-312025-09-300001193125-25-260774EDGAR28K words
2025-07-312025-06-300000950170-25-100917EDGAR—
2025-05-142025-03-310001641172-25-010252EDGAR—
2024-11-122024-09-300001493152-24-044736EDGAR—
2024-08-072024-06-300001493152-24-030603EDGAR—
2024-05-142024-03-310001493152-24-019225EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001193125-26-142089EDGAR1K words
2026-04-020001193125-26-140044EDGAR—
2026-03-060001193125-26-096474EDGAR—
2026-02-230001193125-26-064040EDGAR—
2026-02-060001193125-26-041187EDGAR—
2026-01-020001193125-26-001077EDGAR—
2025-12-150001193125-25-319441EDGAR—
2025-11-250001193125-25-294634EDGAR—
2025-11-190001193125-25-288264EDGAR—
2025-08-080000950170-25-105807EDGAR—

71 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001958777
TickerFBLG
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ca21544a5d9c334e13c9af5b050cb91b1d1beba734effe7cc24d89af260d6fd6
parent: 3fe75e1ac4e1443175bda5710a05996f03b102544e425e3e2a1b192a37391f0e
content hash: 272eb89fedfdba89da6b8077e90f3f6f386f57f5f378892b9e5726fe1d53a650
signed: 2026-04-13T04:44:59.402Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf